📈 Finance
Markets, economics, and financial intelligence. · 73 articles
Why Bitcoin’s $145,000 Breakout is Dragging the Dow and S&P 500 to All-Time Highs
Bitcoin's surge to $145k sparks a massive S&P 500 and Nasdaq rally. Analyze why crypto and stocks are now perfectly correlated in the 2026 market.
Scott Bessent vs. the Bond Vigilantes: The $32 Trillion War for Global Stability
Treasury Secretary Scott Bessent takes on bond vigilantes in the $32tn market. Discover how this fiscal war impacts your mortgage and global stability.
Scott Bessent’s $32 Trillion Gamble: Can Short-Term Debt Save the Long-Term American Dream?
Analysis of Scott Bessent’s strategy for the $32tn US Treasury market, the shift to short-term debt, and the implications for global financial stability.
Why Charter Communications’ 30% Cash Yield Is the Market’s Most Dangerous Blind Spot
Charter Communications (CHTR) hits 30% free cash flow yield as network upgrades end. Analysis of debt reduction and shareholder return potential.
Moscow’s Dry Pumps: Why the World’s Oil Giant is Running Out of Gas
Moscow faces unprecedented fuel shortages as refinery strikes and supply chain failures leave gas stations empty. Read the 2026 finance report.
The $50 Billion Bet: How Micron is Turning Idaho into Global Silicon Square
Explore how Micron's $50B Boise expansion is reshaping Idaho's economy and securing the global AI supply chain through the CHIPS Act.
Why the Treasury’s Newest Intervention Just Sent Your Portfolio Into a Tailspin
Dow, S&P 500, and Nasdaq drop as Treasury intervention causes bond yields to spike and oil prices to rise. Discover what this means for your 2026 portfolio.
Moderna Stock Explodes 150% as mRNA Cancer Vaccine Smashes Late-Stage Trial Targets
Moderna and Merck announce 65% reduction in melanoma recurrence with new mRNA vaccine. Moderna stock jumps 150% as oncology market shifts.
Lyntris IPO Bloodbath: Why Wall Street Just Deleted $1.4 Billion in Tech Value
Lyntris shares crash 40% in NYSE debut, dropping valuation to $1.8 billion. Analysis of the 2026 tech IPO market and the end of AI hype.
Moderna Stock Rockets 112% as Personalized mRNA Cancer Vaccine Crushes Late-Stage Trials
Moderna and Merck report a 48% reduction in melanoma death risk with new mRNA vaccine. Moderna stock doubles as personalized oncology hits a major milestone.
Moderna Stock Rockets 90% as mRNA Cancer Vaccine Delivers Historic Late-Stage Breakthrough
Moderna shares soar 90% following Phase 3 results of a personalized mRNA cancer vaccine. Discover how Merck and Moderna are disrupting the $200B oncology market
Russia's Western Oil Exports Collapse 15% Below Plan as Shadow Fleet Stalls
Russia's western oil exports drop 15% below targets at Baltic and Black Sea ports, signaling potential failure in the shadow fleet logistics.